We are live on ! Find out more
AT

Arvest Trust Portfolio holdings

AUM $1.68B
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+14.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$915M
AUM Growth
+$41.4M
Cap. Flow
-$10.8M
Cap. Flow %
-1.18%
Top 10 Hldgs %
38.19%
Holding
112
New
13
Increased
21
Reduced
56
Closed
5

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$16.3M
2
DRI icon
Darden Restaurants
DRI
+$14.1M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$1.34M
4
SWN
Southwestern Energy Company
SWN
+$1.22M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$625K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$16.7M
2
GILD icon
Gilead Sciences
GILD
+$13.8M
3
WMT icon
Walmart Inc
WMT
+$10.2M
4
COP icon
ConocoPhillips
COP
+$1.07M
5
XOM icon
ExxonMobil
XOM
+$310K

Sector Composition

Rank Sector Weight
1 Healthcare 11.77%
2 Technology 11%
3 Financials 8.61%
4 Energy 7.98%
5 Consumer Staples 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
26
Pfizer
PFE
$143B
$12.9M 1.41%
471,936
-4,159
-0.9% -$113K
HP icon
27
Helmerich & Payne
HP
$3.45B
$12.7M 1.39%
184,899
-1,250
-0.7% -$82.5K
STT icon
28
State Street
STT
$50.6B
$12.7M 1.39%
192,962
-1,408
-0.7% -$96.3K
FISV
29
Fiserv Inc
FISV
$28.8B
$12.5M 1.37%
495,372
-3,568
-0.7% -$86.3K
PG icon
30
Procter & Gamble
PG
$336B
$12.4M 1.36%
163,959
-1,794
-1% -$143K
ORCL icon
31
Oracle
ORCL
$374B
$12.1M 1.32%
363,539
-2,620
-0.7% -$85K
WFC icon
32
Wells Fargo
WFC
$261B
$11.7M 1.28%
283,190
-1,752
-0.6% -$74.8K
GD icon
33
General Dynamics
GD
$104B
$11.6M 1.27%
132,961
-960
-0.7% -$81.5K
MCD icon
34
McDonald's
MCD
$192B
$11.4M 1.25%
118,447
-940
-0.8% -$91.8K
KO icon
35
Coca-Cola
KO
$377B
$11.4M 1.24%
300,256
-1,589
-0.5% -$62.8K
WMT icon
36
Walmart Inc
WMT
$885B
$11.3M 1.24%
459,207
-404,550
-47% -$10.2M
EEM icon
37
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$11M 1.21%
270,689
+13,919
+5% +$551K
CAT icon
38
Caterpillar
CAT
$375B
$10.8M 1.18%
129,109
-1,069
-0.8% -$90.4K
TRV icon
39
Travelers Companies
TRV
$78.1B
$10.5M 1.15%
124,411
-787
-0.6% -$65.1K
NOV icon
40
NOV
NOV
$6.93B
$9.79M 1.07%
138,914
-1,013
-0.7% -$67.8K
INTC icon
41
Intel
INTC
$455B
$9.68M 1.06%
422,278
-1,988
-0.5% -$45.8K
DD
42
DELISTED
Du Pont De Nemours E I
DD
$9.47M 1.04%
170,227
-1,883
-1% -$103K
JPM icon
43
JPMorgan Chase
JPM
$935B
$9.25M 1.01%
178,886
-1,603
-0.9% -$86K
COF icon
44
Capital One
COF
$128B
$9.25M 1.01%
134,512
-906
-0.7% -$61K
MDLZ icon
45
Mondelez International
MDLZ
$79.5B
$8.99M 0.98%
286,167
-1,651
-0.6% -$51.2K
OXY icon
46
Occidental Petroleum
OXY
$56.8B
$8.2M 0.9%
91,505
-558
-0.6% -$48K
APA icon
47
APA Corp
APA
$13.2B
$7.33M 0.8%
86,099
-809
-0.9% -$67.2K
IVZ icon
48
Invesco
IVZ
$13.1B
$6.78M 0.74%
212,370
-1,373
-0.6% -$43.8K
IVW icon
49
iShares S&P 500 Growth ETF
IVW
$73.8B
$6.16M 0.67%
275,600
+1,928
+0.7% +$42.6K
PPL
50
PPL Corp
PPL
$26.5B
$6.09M 0.67%
215,353
-2,014
-0.9% -$57.8K
1
2
3 4

Similar funds

BPCA
Bank Pictet & Cie (Asia) Singapore $1.57B AUM 25.56% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
H
HoyleCohen San Diego, California $1.32B AUM 27.05% 1-Year Est. Return
PRIG
Payden & Rygel Investment Group Los Angeles, California $1.24B AUM
PO
Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return
LFDLE
La Financiere de L'Echiquier Paris, France $2.29B AUM 37.29% 1-Year Est. Return
GP
Girard Partners King Of Prussia, Pennsylvania $1.06B AUM 17.26% 1-Year Est. Return

Arvest Trust's Q3 2013 Portfolio in Review

As of Q3 2013, Arvest Trust held 112 positions worth $915M, up 4.7% from $873M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Arvest Trust's Q3 2013 filing shows 13 new, 21 increased, 56 reduced and 5 closed positions. Its largest new stake was Allergan plc: 122,320 shares worth $17.7M. The largest sale was Biogen, an estimated $16.7M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Technology and Financials.

  • Arvest Trust's largest Q3 2013 buy was Allergan plc: 122,320 shares worth $17.7M.
  • Arvest Trust added most to iShares MSCI EAFE ETF in Q3 2013, an estimated $1.34M increase.
  • Arvest Trust's biggest Q3 2013 reduction was Biogen, cutting an estimated $16.7M.
  • Arvest Trust fully exited Oneok Partners LP in Q3 2013, selling an estimated $266K.
  • Arvest Trust's ten largest holdings make up 38% of its $915M portfolio in Q3 2013.
  • Arvest Trust opened 13 new positions and closed 5 in Q3 2013.
  • Arvest Trust's portfolio value rose 4.7% quarter-over-quarter to $915M.

Based on Arvest Trust's 13F filing for Q3 2013, filed 21 Nov 2013.